{"id":22672,"date":"2026-11-22T11:49:22","date_gmt":"2026-11-22T11:49:22","guid":{"rendered":"https:\/\/qiraatafrican.com\/en\/?p=22672"},"modified":"2026-11-22T11:49:22","modified_gmt":"2026-11-22T11:49:22","slug":"scientists-are-learning-more-about-the-rare-ebola-virus-in-congo-outbreak","status":"publish","type":"post","link":"https:\/\/qiraatafrican.com\/en\/22672\/scientists-are-learning-more-about-the-rare-ebola-virus-in-congo-outbreak\/","title":{"rendered":"Scientists are learning more about the rare Ebola virus in Congo outbreak"},"content":{"rendered":"<p>More than six months into a devastating Ebola outbreak in the Democratic Republic of Congo, scientists and medics are beginning to gain a better understanding of the rare Bundibugyo version of the virus, which they hope can help explain its rapid spread \u200band, ultimately, stop it.<\/p>\n<p>There have been more than 11,000 cases and over 5,500 deaths so far, with the Bundibugyo virus spreading at double the pace of the 2014-2016 Ebola outbreak \u200cin West Africa, the largest on record. There are no licensed treatments or vaccines to fight it.<\/p>\n<p>The outbreak\u2019s location in a part of eastern Congo already facing a humanitarian crisis could be complicating what scientists are finding, several experts said, and cautioned against drawing early conclusions as data is limited, varied and often difficult to collect.<\/p>\n<p>\u201cThere are so many different factors to compare across outbreaks, even within outbreaks \u2014 it is really hard,\u201d said Daniel Bausch, a member of the World Health Organization\u2019s Ebola \u200bemergency committee and visiting professor at the Geneva Graduate Institute in Switzerland.<\/p>\n<p>Catherine Smallwood, the WHO&#8217;s Ebola incident manager, said teams were gathering evidence to help better inform the response.<\/p>\n<p>\u201cSoon we\u2019ll be able \u200bto make some bold statements about what\u2019s the same, what\u2019s different, and what we need to adjust,\u201d she said.<\/p>\n<p><strong>BLEEDING LESS COMMON<\/strong><\/p>\n<p>A key area of investigation centers on \u2060Bundibugyo\u2019s symptoms, particularly in children, WHO and Africa Centres for Disease Control and Prevention officials told Reuters.<\/p>\n<p>Infection with Ebola can cause fever, vomiting, diarrhea and, in severe cases, internal and external bleeding.<\/p>\n<p>But bleeding is \u200bonly occurring in around 5% to 10% of confirmed cases in the Bundibugyo outbreak, said Yap Boum, Africa CDC\u2019s deputy Ebola incident manager, making it less common than in outbreaks of the more prevalent Ebola, Zaire.<\/p>\n<p>This \u200bmakes the disease easier to confuse with other more common illnesses like malaria, which Boum said could have contributed to the late detection of the outbreak alongside early challenges with diagnosis, as the tests designed for other Ebola species do not pick up Bundibugyo.<\/p>\n<p>It is also making it harder to track the spread, as many people do not suspect Ebola and seek care. Around 70% of patients are still dying in their communities rather than in healthcare centres.<\/p>\n<p>While the outbreak was declared in \u200bMay, the WHO and Africa CDC believe transmission may have been occurring months before that.<\/p>\n<p>Jean-Jacques Muyembe, co-discoverer of Ebola and the head of Congo\u2019s National Institute for Biomedical Research, said bleeding was also occurring later \u200bin the disease for some patients.<\/p>\n<p>Bausch said many scientists now think bleeding is less of a hallmark symptom of all Ebola disease than they used to based on data gathered over years, although it seems even more rare for \u200cBundibugyo patients.<\/p>\n<p><strong>RISK <\/strong><strong>\u2060<\/strong><strong>TO CHILDREN<\/strong><\/p>\n<p>In young children, the situation is even more complex, said the WHO&#8217;s Smallwood.<\/p>\n<p>Gastrointestinal symptoms are more common than fever, complicating early diagnosis and treatment, which could also be a reason why children are being disproportionately affected, she said.<\/p>\n<p>There have been 1,207 confirmed cases of Ebola in children under the age of 5, and 844 of them have died, roughly 7 in 10, according to the latest data from the Congolese ministry of health and the WHO.<\/p>\n<p>That is higher than among adults, for whom the fatality rate is around 50%, which is above previous Bundibugyo outbreaks but below the typical rates for Zaire, Muyembe and other types of Ebola, \u200bwhich can be up to 80% without treatment.<\/p>\n<p><strong>REMAINING <\/strong><strong>\u200b<\/strong><strong>QUESTIONS<\/strong><\/p>\n<p>There are still many questions that need further \u2060study, half-a-dozen leading experts said, including how common it is for patients to experience mild symptoms, as well as the long-term implications of infection for survivors. Around 700 survivors have enrolled in a study and support schemes, the WHO said.<\/p>\n<p>Genomic sequencing, which previously found distinct differences from more common Ebola viruses, shows Bundibugyo \u200bis not changing rapidly or becoming more transmissible.<\/p>\n<p>But Sylvie Jonckheere, M\u00e9decins Sans Fronti\u00e8res&#8217; emerging and reemerging infectious diseases adviser, said research remained a challenge when so \u200bmany cases were still not \u2060being identified before victims die in the community.<\/p>\n<p>\u201cIf we don&#8217;t find the ones that are severely sick, what is our hope of finding the ones that are only mildly sick?\u201d she said.<\/p>\n<p>Prompt access to good care massively improves the chance of survival, the experts said.<\/p>\n<p>Several experts noted that progress in stamping out the outbreak in some of the early hotspots demonstrated that standard control measures, like isolating patients, do work. Like Zaire, this virus seems \u2060only to transmit \u200bwhen patients are symptomatic.<\/p>\n<p>But the big research question remains what vaccines and treatments could be effective.<\/p>\n<p>A trial of Merck\u2019s Ervebo vaccine, \u200bdeveloped to prevent Zaire, is assessing whether it might offer cross-protection for Bundibugyo.<\/p>\n<p>New vaccines developed for Bundibugyo specifically will also enter trials soon, and medics are testing prophylactic antivirals and treatments in Congo from Gilead Sciences and Mapp Biopharmaceutical.<\/p>\n<p>\u201cWhen we started, we said there \u200bare no vaccines, no treatments,&#8221; Boum said. &#8220;If we start proving we have some efficacy&#8230; it becomes a game changer.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>More than six months into a devastating Ebola outbreak in the Democratic Republic of Congo, scientists and medics are beginning to gain a better understanding of the rare Bundibugyo version of the virus, which they hope can help explain its rapid spread \u200band, ultimately, stop it. There have been more than 11,000 cases and over [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":21447,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"iawp_total_views":0,"jnews-multi-image_gallery":[],"jnews_single_post":{"format":"standard","override":[{"template":"1","parallax":"1","fullscreen":"1","layout":"right-sidebar","sidebar":"default-sidebar","second_sidebar":"default-sidebar","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_featured":"1","show_post_meta":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_reading_time":"0","post_reading_time_wpm":"300","post_calculate_word_method":"str_word_count","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_comment_section":"1","number_popup_post":"1","show_post_related":"1","show_inline_post_related":"1"}],"image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post_position":"meta","trending_post_label":"Trending","sponsored_post_label":"Sponsored by","disable_ad":"0","source_name":"Reuters","subtitle":""},"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":{"view_counter_number":"0","share_counter_number":"0","like_counter_number":"0","dislike_counter_number":"0"},"footnotes":""},"categories":[28,29,2362,2854],"tags":[5640,4392],"class_list":["post-22672","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-central-africa","category-east-africa","category-featured","category-health","tag-congo-outbreak","tag-ebola-virus"],"_links":{"self":[{"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/posts\/22672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/comments?post=22672"}],"version-history":[{"count":1,"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/posts\/22672\/revisions"}],"predecessor-version":[{"id":22673,"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/posts\/22672\/revisions\/22673"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/media\/21447"}],"wp:attachment":[{"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/media?parent=22672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/categories?post=22672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/qiraatafrican.com\/en\/wp-json\/wp\/v2\/tags?post=22672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}